StockNews.AI
LMAT
StockNews.AI
204 days

LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025

1. LeMaitre Vascular will report Q4 2024 results on February 27, 2025. 2. A conference call is scheduled for 5:00 PM EST the same day. 3. LeMaitre focuses on treatments for peripheral vascular disease affecting 200 million globally. 4. Results may influence investor sentiment and stock performance of LMAT.

3m saved
Insight
Article

FAQ

Why Neutral?

The scheduled earnings call is standard, but results could surprise investors.

How important is it?

Earnings reports generally affect stock performance, including LMAT's market perception.

Why Short Term?

Earnings results and conference call outcomes typically impact short-term stock movements.

Related Companies

LMAT
BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Related News